Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

N/AUnknownNCT03904329

Assiut University1 enrolled

Overview

Obesity paradox In patient with non valvular atrial fibrillation

Study role of obesity in outcomes of anticoagulation in patients with non valvular atrial fibrillation

Study Type

OBSERVATIONAL

Enrollment

Conditions

Obesity Paradox

Interventions

Oral AnticoagulantDRUG

Oral tablets of anti coagulations either warfare or NOACs

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients presented with non valvular AF * patients on oral anticoagulant Exclusion Criteria: * valvular AF * Mental illness * History of cerebrovascular stroke * history of bleeding tendency * history of Chronic renal failure

Locations (1)

Kristen amir

Asyut, Egypt

RECRUITING

Outcomes

Primary Outcomes

Correlation between obesity and outcomes in non valvular atrial fibrillation

To study effect of obesity in outcomes of non valvular atrial fibrillation regarding the effect of obesity in the outcome of anticoagulants

Time frame: Sixth months

Central Contacts

Christen Henan, Ressident

CONTACT

01201558854 Christenamir@yahoo.com

Mahmmoed Abd e El saAbour, Assissetant professor

CONTACT

01001202779 M_abd_elsabour@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.